Halaman 2 - Tumor Desmoid Dokter Terbaik - TOP-48 dokter

Dr. Muzaffer Al berspesialisasi dalam bedah laparoskopi dan onkologi di Rumah Sakit Büyük Anadolu, dengan pelatihan lanjutan dalam teknik invasif minimal.

• Tersertifikasi dalam bedah umum dengan pengalaman lebih dari 20 tahun
• Spesialisasi dalam bedah antirefluks laparoskopi dan bariatrik
• Terlatih dalam bedah kanker onkologi di Universitas Istanbul

Assoc. Prof. Nail Paksoy spesialis dalam pengobatan Tumor Desmoid dengan penelitian yang dipublikasikan mengenai kemanjuran sorafenib untuk kasus simptomatik – sekarang berada di Rumah Sakit Medipol Bahçelievler.

• Sertifikasi Dewan ESMO dalam Onkologi Medis
• Fokus penelitian pada sarkoma dan tumor langka
• Sub-investigator dalam 8 uji klinis internasional

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Spesialis dalam viroterapi – pendekatan imunologi mutakhir – Dr. Jaunalksne membawa 30+ tahun keahlian dalam pengobatan Tumor Desmoid.

• Kepala Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulusan Institut Medis Riga dengan magang di Kedokteran Internal
• Berfokus pada metode pengobatan imunologi inovatif

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Volkan Kinas berspesialisasi dalam bedah onkologi, termasuk pengobatan tumor desmoid, di Rumah Sakit Büyük Anadolu.

• Ahli dalam bedah kanker dengan fokus pada kasus-kasus kompleks
• Melakukan bedah pankreas dan saluran empedu di samping prosedur onkologi
• Terampil dalam bedah kanker payudara dan tiroid

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Spesialis onkologi radiasi di Universitas Marmara – salah satu sekolah kedokteran terkemuka di Turki.

• Menyelesaikan pelatihan ketat dalam onkologi radiasi dari tahun 2012 hingga 2016
• Fasih berbahasa Inggris dengan latar belakang pendidikan medis internasional
• Bekerja di Rumah Sakit Emsey – sebuah pusat onkologi khusus

Dr. López-Ibor adalah spesialis hematologi dan onkologi pediatrik dengan pengalaman lebih dari 20 tahun, yang saat ini memimpin Unit Hematologi dan Onkologi Pediatrik di Rumah Sakit HM Montepríncipe.

• Ahli dalam mengobati tumor tulang dan otak
• Menempuh pendidikan di University of Maryland
• Penulis berbagai publikasi ilmiah
• Sebelumnya mengepalai unit yang sama di Hospital Universitario Clínica San Rafael

Profesor Ersin Ozturk membawa keahlian luas dalam bedah onkologi, dengan pelatihan khusus dalam bedah gastrointestinal dan fisiologi.

• Lebih dari 20 tahun pengalaman dalam bedah umum
• Pelatihan fellowship di Departemen Bedah Kolorektal Cleveland Clinic
• Profesor di Rumah Sakit Medicana Bursa, memimpin departemen bedah umum
• Spesialisasi dalam pendekatan bedah tradisional maupun laparoskopi